For immediate release |
11 May 2015 |
Futura Medical plc
("Futura" or "the Company")
Blue Diamond® Retail Roll-out
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce that Blue Diamond®, the Company's own brand of its novel CSD500 condom, is shortly to be distributed to more than 600 drug stores throughout the Netherlands, opening up a high street channel to complement the product's online sales.
Blue Diamond® was launched online in the Netherlands in October last year by Futura's distribution partner in the region. The product's availability in-store is an encouraging step as approximately 75% of condom sales are transacted through the drug store channel in the Netherlands.
The 600 drug stores in which Blue Diamond® will be stocked are owned by two of the largest drug store chains in the Netherlands. The in-store launch of Blue Diamond® will be accompanied by an advertising campaign including targeted radio advertising and in-store promotion.
James Barder, Futura's Chief Executive, commented: "Following the online launch of the Blue Diamond® brand in the Netherlands last year, it is encouraging that the product will now also be available in more than 600 drug stores in the country. We look forward to monitoring the sales progress of Blue Diamond® during the months ahead."
For further information please contact:
Futura Medical plc |
|
James Barder, Chief Executive |
Tel: +44 (0) 1483 685 670 |
Email to: [email protected] |
www.futuramedical.com |
N+1 Singer (Nominated Adviser and Broker) |
|
Aubrey Powell / Tom Smale - Corporate Finance |
Tel:+44 (0) 20 7496 3000 |
For media enquiries please contact: |
|
Buchanan |
|
Mark Court / Sophie Cowles / Stephanie Watson |
Tel: +44 (0) 20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com
